Cindy Eckert

Cindy Eckert serves as CEO at Sprout Pharmaceuticals, Inc.. Sprout Pharmaceuticals, Inc. operates in the pharmaceuticals sector with approximately 34.0 employees. Sprout Pharmaceuticals, Inc. generates annual revenue of 6000000.0. To date, Sprout Pharmaceuticals, Inc. has raised 82396137.0 in total funding, with the most recent round being Convertible Note.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • Our database includes 201,469 c suite-level executives.

Gmail Google Apps Amazon AWS Typekit Mobile Friendly Google Analytics Google Tag Manager Remote

biotechnology life sciences pharmaceutical manufacturing womens sexual health fda approved pill female libido addyi brand partnerships marketing targets influencer program collaborations strategic partnerships revenue generation patient support healthcare professionals digital media crm software agile development software development product education health campaigns social influencers medical platforms communication skills data driven innovative technology healthcare marketing user experience collaborative culture medical sales health insurance digital engagement content marketing customer acquisition relationship building negotiation skills technical documentation feedback evaluation software integration market dynamics program development success metrics job opportunities remote work employee benefits stock options user support problem solving software engineering data analysis clinical research corporate culture growth mindset pharmaceuticals medical information technology & services ux marketing & advertising data analytics

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Cindy Eckert in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Sprout Pharmaceuticals, Inc..

Cindy Eckert's Position in the MessageCEO Database

• •Cindy Eckert is 1 of 1 verified executive contact we track at Sprout Pharmaceuticals, Inc..
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •10 verified contacts work at pharmaceuticals companies in the 34.0 employee range (same size as Sprout Pharmaceuticals, Inc.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Cindy Eckert directly?

Cindy Eckert's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Sprout Pharmaceuticals, Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Cindy Eckert work for?

Cindy Eckert is CEO at Sprout Pharmaceuticals, Inc., a company in the pharmaceuticals sector with 34.0 employees.

Can I pitch or sell to Cindy Eckert?

As CEO at Sprout Pharmaceuticals, Inc., Cindy Eckert is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Cindy Eckert directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Cindy Eckert in?

Cindy Eckert works in the pharmaceuticals industry as CEO at Sprout Pharmaceuticals, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Cindy Eckert's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Cindy Eckert's profile is kept up-to-date with the latest available information.

Last updated: June 22, 2026